This initial order of 50,000 grams of the Miller thermally purified graphite is to be used in the development of a Certified Reference Material ('CRM') for the analysis of ultra-high purity graphite samples. The CRM will be developed and marketed by LGC, with a retail selling price comparable to the lower purity BAM S009 (NBG 18) reference material. The order is renewable for 100,000 gram lots, on the same terms. Additional CRM materials based on Miller graphite are also under development by the two companies.
Subsequent to the initial order being placed, and as a result of on-going collaborative discussions with the team at ARMI over the last few months, it became apparent that it would be prudent to undertake thermal purification optimization efforts in order to establish scaled-up and reproducible purification procedures prior to delivery of the first order. Not only have these efforts provided engineering data suitable for a feasibility level economic study, subsequent orders with the initial CRM ultra-high purity graphite specifications could be guaranteed to be delivered with the same characteristics, consistently and without delay (a level of security demanded in the CRM space). This collaborative process will allow
The initial batch of purified Miller graphite has met LGC's specifications, which include meeting a purity threshold of 99,995+% carbon. At this purity level, there are trace but quantifiable amounts of elemental impurities in the graphite. Contrary to what many might expect for an ultra-high purity graphite CRM, the graphite cannot be too pure or it becomes useless for calibrating instruments intended to measure the impurity content of unknown graphite samples. By providing precisely measured trace amounts of a number of impurities, the CRM can serve its purpose of instrumental calibration for many impurities simultaneously.
Executive Chairman and CEO
About
LGC is an international leader in the extended life sciences sector, including human healthcare, agri-food & the environment. LGC's 2,300 employees include internationally-recognized scientists who are experts in their field. Headquartered in
LGC provides a comprehensive range of reference materials, proficiency testing schemes, genomics reagents and instrumentation, research and measurement services. Its scientific tools and solutions form an essential part of our customers' quality and compliance procedures enabling them to provide safer products, develop new solutions and advance research.
Through a collaborative and consultative approach, LGC's products and technology platforms help their customers bring new therapies to market; optimize food safety and production; enable diagnoses to be made more accurately and support progressing product discovery through to manufacture with quality and consistency. In this way, LGC plays its part in addressing important global drivers such as a growing and ageing population, globalization and rise of emerging markets.
Contact:
Tel: (416) 903-8408
FORWARD LOOKING STATEMENTS
This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in
(C) 2020 Electronic News Publishing, source